Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma

Jan C. Buckner^*, Mark G. Malkin, Eddie Reed, Terrence L. Cascino, Joel M. Reid, Matthew M. Ames, William P.Y. Tong, Silam Lim, William D. Figg

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review